NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...
GABAA receptors are the principal mediators of fast inhibitory neurotransmission in the mammalian brain. Each receptor is a pentameric chloride‐selective ion channel assembled from a repertoire of 19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results